Evidence map›Paper›PMID 26235224›Full record

ArticleGenome biology2015

Dynamics of gene silencing during X inactivation using allele-specific RNA-seq.

Hendrik Marks, Hindrik H D Kerstens, Tahsin Stefan Barakat, Erik Splinter, René A M Dirks, Guido van Mierlo, Onkar Joshi, Shuang-Yin Wang, Tomas Babak, Cornelis A Albers and 6 more

Erratum issuedAbstract read
In one paragraph

Article in Genome biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Hendrik MarksRadboud University, Faculty of Science, Department of Molecular Biology, Radboud Institute for Molecular Life Sciences (RIMLS), 6500HB, Nijmegen, The Netherlands. H.Marks@ncmls.ru.nl.
Hindrik H D KerstensRadboud University, Faculty of Science, Department of Molecular Biology, Radboud Institute for Molecular Life Sciences (RIMLS), 6500HB, Nijmegen, The Netherlands. H.Kerstens@ncmls.ru.nl.
Tahsin Stefan BarakatDepartment of Reproduction and Development, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Stefan.Barakat@ed.ac.uk.
Erik SplinterHubrecht Institute, University Medical Center Utrecht, Uppsalalaan 8, 3584CT, Utrecht, The Netherlands. Erik.Splinter@cergentis.com.
René A M DirksRadboud University, Faculty of Science, Department of Molecular Biology, Radboud Institute for Molecular Life Sciences (RIMLS), 6500HB, Nijmegen, The Netherlands. R.Dirks@ncmls.ru.nl.
Guido van MierloRadboud University, Faculty of Science, Department of Molecular Biology, Radboud Institute for Molecular Life Sciences (RIMLS), 6500HB, Nijmegen, The Netherlands. G.vanMierlo@science.ru.nl.
Onkar JoshiRadboud University, Faculty of Science, Department of Molecular Biology, Radboud Institute for Molecular Life Sciences (RIMLS), 6500HB, Nijmegen, The Netherlands. O.Joshi@ncmls.ru.nl.
Shuang-Yin WangRadboud University, Faculty of Science, Department of Molecular Biology, Radboud Institute for Molecular Life Sciences (RIMLS), 6500HB, Nijmegen, The Netherlands. S.Wang@ncmls.ru.nl.
Tomas BabakBiology Department, Queen's University, Kingston, ON, Canada. tomas.babak@queensu.ca.
Cornelis A AlbersRadboud University, Faculty of Science, Department of Molecular Developmental Biology, Radboud Institute for Molecular Life Sciences (RIMLS), 6500HB, Nijmegen, The Netherlands. Kees.Albers@radboudumc.nl.
Tüzer KalkanWellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QR, UK. tk360@cam.ac.uk.
Austin SmithWellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QR, UK. Austin.Smith@cscr.cam.ac.uk.
Alice JouneauINRA, UMR1198 Biologie du Développement et Reproduction, F-78350, Jouy-en-Josas, France. Alice.Jouneau@jouy.inra.fr.
Wouter de LaatHubrecht Institute, University Medical Center Utrecht, Uppsalalaan 8, 3584CT, Utrecht, The Netherlands. W.Laat@hubrecht.eu.
Joost GribnauDepartment of Reproduction and Development, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. J.Gribnau@erasmusmc.nl.
Hendrik G StunnenbergRadboud University, Faculty of Science, Department of Molecular Biology, Radboud Institute for Molecular Life Sciences (RIMLS), 6500HB, Nijmegen, The Netherlands. H.Stunnenberg@ncmls.ru.nl.

Funding

Medical Research Council G1001028Medical Research Council G1100526Medical Research Council MC_PC_12009Wellcome Trust 97922
6 · The paper itself

Abstract

backgroundDuring early embryonic development, one of the two X chromosomes in mammalian female cells is inactivated to compensate for a potential imbalance in transcript levels with male cells, which contain a single X chromosome. Here, we use mouse female embryonic stem cells (ESCs) with non-random X chromosome inactivation (XCI) and polymorphic X chromosomes to study the dynamics of gene silencing over the inactive X chromosome by high-resolution allele-specific RNA-seq.

resultsInduction of XCI by differentiation of female ESCs shows that genes proximal to the X-inactivation center are silenced earlier than distal genes, while lowly expressed genes show faster XCI dynamics than highly expressed genes. The active X chromosome shows a minor but significant increase in gene activity during differentiation, resulting in complete dosage compensation in differentiated cell types. Genes escaping XCI show little or no silencing during early propagation of XCI. Allele-specific RNA-seq of neural progenitor cells generated from the female ESCs identifies three regions distal to the X-inactivation center that escape XCI. These regions, which stably escape during propagation and maintenance of XCI, coincide with topologically associating domains (TADs) as present in the female ESCs. Also, the previously characterized gene clusters escaping XCI in human fibroblasts correlate with TADs.

conclusionsThe gene silencing observed during XCI provides further insight in the establishment of the repressive complex formed by the inactive X chromosome. The association of escape regions with TADs, in mouse and human, suggests that TADs are the primary targets during propagation of XCI over the X chromosome.

Indexed as

Gene SilencingX Chromosome InactivationAllelesAnimalsChromatinEmbryoid BodiesEmbryonic Stem CellsFemaleHumansMiceNeural Stem CellsSequence Analysis, RNAChromatin

Identifiers

PMID26235224
PMCPMC4546214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.